Status:
COMPLETED
Study of the Interaction Between the Cells Lining Blood Vessels and Angiotensin-Converting Enzyme
Lead Sponsor:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Atherosclerosis
Coronary Disease
Eligibility:
All Genders
Brief Summary
The walls of blood vessels are lined by flat cells that are responsible for releasing substance(s) that control the activity of the blood vessel. These cells are referred to as the endothelium of the ...
Detailed Description
The vascular endothelium tonically releases nitric oxide that produces smooth muscle relaxation, inhibition of platelet aggregation, and inhibition of cellular proliferation. Studies in the Cardiology...
Eligibility Criteria
Anyone with chest pain with known or suspected coronary artery disease.
Key Trial Info
Start Date :
March 1 1995
Trial Type :
OBSERVATIONAL
End Date :
April 1 2001
Estimated Enrollment :
209 Patients enrolled
Trial Details
Trial ID
NCT00001461
Start Date
March 1 1995
End Date
April 1 2001
Last Update
March 4 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Heart, Lung and Blood Institute (NHLBI)
Bethesda, Maryland, United States, 20892